Technical University Munich-ko ikertzaileekin lankidetzan egindako argitalpenak (61)

2024

  1. A transdiagnostic group exercise intervention for mental health outpatients in Germany (ImPuls): results of a pragmatic, multisite, block-randomised, phase 3 controlled trial

    The Lancet Psychiatry, Vol. 11, Núm. 6, pp. 417-430

  2. Changes in the prevalence of mental health problems during the first year of the pandemic: a systematic review and dose-response meta-analysis

    BMJ Mental Health, Vol. 27, Núm. 1

  3. Frequency and Longitudinal Course of Behavioral and Neuropsychiatric Symptoms in Participants with Genetic Frontotemporal Dementia

    Neurology, Vol. 103, Núm. 8

  4. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Journal of Extracellular Vesicles, Vol. 13, Núm. 2

  5. Transatlantic analysis of patient profiles and mid-term survival after isolated coronary artery bypass grafting: a head-to-head comparison between the European DuraGraft Registry and the US STS Registry

    Frontiers in Cardiovascular Medicine, Vol. 11

  6. Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment

    Clinical Gastroenterology and Hepatology, Vol. 22, Núm. 5, pp. 994-1004.e10

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Concept and study protocol of the process evaluation of a pragmatic randomized controlled trial to promote physical activity in outpatients with heterogeneous mental disorders-the ImPuls study

    Trials, Vol. 24, Núm. 1, pp. 330

  3. EFOMP policy statement NO. 19: Dosimetry in nuclear medicine therapy – Molecular radiotherapy

    Physica Medica, Vol. 116

  4. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

2022

  1. Bcl-xL as prognostic marker and potential therapeutic target in cholangiocarcinoma

    Liver International, Vol. 42, Núm. 12, pp. 2855-2870

  2. Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity

    Human Genetics, Vol. 141, Núm. 1, pp. 147-173

  3. Detailed stratified GWAS analysis for severe COVID-19 in four European populations

    Human Molecular Genetics, Vol. 31, Núm. 23, pp. 3945-3966

  4. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  5. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)

    Nature

  6. Stroke genetics informs drug discovery and risk prediction across ancestries

    Nature, Vol. 611, Núm. 7934, pp. 115-123

2021

  1. Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality

    Journal of Clinical Investigation, Vol. 131, Núm. 23

  2. Efficacy and cost-effectiveness of a Transdiagnostic group-based exercise intervention: study protocol for a pragmatic multi-site randomized controlled trial

    BMC Psychiatry, Vol. 21, Núm. 1

  3. Long-term follow-up after recanalisation of aortic arch atresia

    EuroIntervention, Vol. 16, Núm. 15, pp. E1274-E1280

  4. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477